Pancreatic Cancer Research

ResearcherZhengzhou UniversityActive in the last 2 years

Mingzhi Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3581-551X; OpenAlex author ID A5100348441. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. PD-L1 knockout or ZG16 overexpression inhibits PDAC progression and modulates TAM polarization. Last author DOI 10.3389/fimmu.2025.1510179↗
  2. ZG16 enhances the maturation of dendritic cells via induction of CD40 and contributes to the antitumor immunity in pancreatic cancer. Last author DOI 10.1038/s41388-024-03154-6↗
  3. Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. Last author DOI 10.1371/journal.pone.0059203↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hui Meng · 2 shared papers, 2024–2025 · strength 0.54
  2. Zhaoming Li · 1 shared paper, 2013 · strength 0.03
  3. Wang Ma · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.